A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
ABSTRACT Ebola virus (EBOV) causes highly lethal disease outbreaks against which no FDA-approved countermeasures are available. Although many host factors exploited by EBOV for cell entry have been identified, including host cell surface phosphatidylserine receptors, endosomal cysteine proteases, an...
Guardado en:
Autores principales: | J. Maximilian Fels, Jennifer S. Spence, Robert H. Bortz, Zachary A. Bornholdt, Kartik Chandran |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20567a5fc6a94a1da98fb64f9492e78d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
por: O'Donnell KL, et al.
Publicado: (2021) -
Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
por: Brandyn R. West, et al.
Publicado: (2018) -
Modeling Ebola Virus Transmission Using Ferrets
por: Marc-Antoine de La Vega, et al.
Publicado: (2018) -
A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles
por: Esther Ndungo, et al.
Publicado: (2016) -
Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection
por: Emily Speranza, et al.
Publicado: (2020)